NIDDM PRIMARY PREVENTION TRIAL (DPT 2)

Project: Research project

StatusActive
Effective start/end date8/15/941/31/21

Funding

  • National Institutes of Health: $411,418.00
  • National Institutes of Health: $519,976.00
  • National Institutes of Health: $351,000.00
  • National Institutes of Health: $391,122.00
  • National Institutes of Health: $315,791.00
  • National Institutes of Health: $221,418.00
  • National Institutes of Health: $391,122.00
  • National Institutes of Health: $349,101.00
  • National Institutes of Health: $30,852.00
  • National Institutes of Health: $493,878.00
  • National Institutes of Health: $455,840.00
  • National Institutes of Health: $563,473.00
  • National Institutes of Health: $452,221.00
  • National Institutes of Health: $455,840.00
  • National Institutes of Health
  • National Institutes of Health: $833,285.00
  • National Institutes of Health: $825,316.00
  • National Institutes of Health: $384,533.00
  • National Institutes of Health: $504,329.00
  • National Institutes of Health: $555,968.00

Fingerprint

Glucose Intolerance
Type 2 Diabetes Mellitus
Metformin
Outcome Assessment (Health Care)
Life Style
Primary Prevention
Cardiovascular Diseases
Population
Exercise
Gestational Diabetes
Atherosclerosis
African Americans
Volunteers
Behavior Therapy
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.)
Placebos
Glucose
Research
Incidence
Public Health

ASJC

  • Medicine(all)